Boston Scientific (BSX) Work In Process (2009 - 2026)

Boston Scientific (BSX) has 18 years of Work In Process data on file, last reported at $259.0 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process rose 18.81% year-over-year to $259.0 million; the trailing twelve-month figure through Mar 2026 stood at $259.0 million (up 18.81% YoY), and the FY2025 full-year result was $246.0 million, up 27.46% from the prior year.
• Work In Process climbed to $259.0 million in Q1 2026, from $246.0 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $259.0 million in Q1 2026 to a low of $142.0 million in Q1 2022.
• A 5-year average of $192.2 million and a median of $188.0 million in 2024 frame the typical range for Work In Process.
• Across the five-year window, Work In Process increased 6.82% in 2024 and advanced 27.46% in 2025, its largest moves.
• Tracing BSX's Work In Process over 5 years: stood at $147.0 million in 2022, then rose by 18.37% to $174.0 million in 2023, then climbed by 10.92% to $193.0 million in 2024, then increased by 27.46% to $246.0 million in 2025, then advanced by 5.28% to $259.0 million in 2026.
• Business Quant data shows BSX's Work In Process at $259.0 million in Q1 2026, $246.0 million in Q4 2025, and $245.0 million in Q3 2025.